Learn more about group purchasing and volume discount pricing.
Description
Ototoxicity is a common but frequently underrecognized side effect of cancer treatment, particularly with platinum-based therapies. It can lead to hearing loss, tinnitus, balance disturbances, and long-term impacts on patient safety and quality of life.
This recorded webinar provides oncology nurses with a focused, practical overview of cancer treatment-related ototoxicity. Learners will explore how ototoxicity develops, which patients are at higher risk, and how it presents across the care continuum. The session also highlights the broader patient impact, including communication challenges, safety concerns, and survivorship considerations.
A key emphasis of this webinar is the role of the nurse in early identification and intervention. Ototoxicity is not consistently assessed in routine oncology care, creating a gap in practice. This session provides clear, actionable strategies to help nurses recognize early symptoms, incorporate hearing-related assessment into patient encounters, and respond appropriately through documentation, escalation, and referral.
This resource was developed by ONS through an educational grant from Fennec Pharmaceuticals, Inc. ONS is solely responsible for the criteria, objectives, content, quality, and scientific integrity of its programs and publications.
Your access no longer expires after 180 days. From the date of purchase, you will have access to this course for as long as it remains available. If a new version of the course becomes available, you will need to purchase it for access.
Features
This activity includes:
- Focused education on ototoxicity, a commonly overlooked treatment-related toxicity
- Strong emphasis on practical, nurse-driven actions that can be applied in clinical practice
- Clear guidance on integrating ototoxicity assessment into routine patient care workflows
- Real-world context highlighting patient safety, communication challenges, and quality of life impact
- Case-based example to reinforce clinical decision-making and application
- Emphasis on interdisciplinary collaboration and timely escalation
- 180 days of access to the webinar recording
- Automated email delivery with access instructions
Presenter
Jennessa Rooker, PhD, RN, OCN is the Director of Nursing Excellence at Tampa General Hospital's Cancer Institute. A recent PhD graduate from the University of South Florida, her program of research focused on the use of portable technology to measure and monitor ototoxicity in adult patients receiving cisplatin chemotherapy. She has worked as a registered nurse at Tampa General Hospital for 10 years, with experience spanning inpatient oncology, outpatient infusion nursing, and clinical education. In her current role, she supports frontline nursing involvement in evidence-based practice, quality improvement, and nursing research. Her future research interests include scaling remote ototoxicity monitoring through mixed methods research to reach more patients at risk for hearing loss and tinnitus.
Course Topics
This activity covers:
- Definition of ototoxicity and common causative agents, including chemotherapy
- Pathophysiology of treatment-related hearing loss and tinnitus
- Risk factors, including patient characteristics and treatment exposures
- Clinical manifestations, including tinnitus, hearing loss, and balance disturbances
- Impact on patient communication, safety, quality of life, and survivorship outcomes
- Early identification and symptom recognition strategies
- Nursing assessment, documentation, and escalation of ototoxicity
- Interdisciplinary care coordination, including referral to audiology
- Management approaches, monitoring, and survivorship considerations
Expected Outcomes
Upon completion of this activity, learners will increase their knowledge of how to identify, assess, and respond to ototoxicity in patients receiving cancer treatment, supporting earlier intervention and improved patient outcomes.
Target Audience
This webinar is designed for oncology nurses across care settings, including clinic, infusion, radiation, and survivorship, who assess and manage treatment-related toxicities and want to improve their ability to recognize and respond to hearing-related side effects.
Accreditation
The Oncology Nursing Society is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Course Cancellation Policy
If you wish to cancel your online course registration, you must notify ONS within 30 days of the purchase date and prior to beginning the course. No cancellation will be accepted after the course has been accessed or after the 30-day purchase window.
Request a cancellation via email to help@ons.org. If your request is eligible, ONS will issue a monetary refund equal to the cost of the course registration minus a 30% cancellation fee.
Earn Contact Hours
Browse our selection of courses, activities & conferences.